AdvanSix Valuation

Is ASIX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ASIX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ASIX ($30.68) is trading below our estimate of fair value ($94.68)

Significantly Below Fair Value: ASIX is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ASIX?

Other financial metrics that can be useful for relative valuation.

ASIX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA12.3x
PEG Ratio0.8x

Price to Earnings Ratio vs Peers

How does ASIX's PE Ratio compare to its peers?

The above table shows the PE ratio for ASIX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11x
WLKP Westlake Chemical Partners
14xn/aUS$795.9m
KOP Koppers Holdings
9.6x7.2%US$759.8m
OEC Orion
12.8x36.2%US$1.0b
SIRE Sisecam Resources
7.6xn/aUS$511.9m
ASIX AdvanSix
96.7x117.6%US$819.6m

Price-To-Earnings vs Peers: ASIX is expensive based on its Price-To-Earnings Ratio (96.7x) compared to the peer average (12.1x).


Price to Earnings Ratio vs Industry

How does ASIX's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: ASIX is expensive based on its Price-To-Earnings Ratio (96.7x) compared to the US Chemicals industry average (26.6x).


Price to Earnings Ratio vs Fair Ratio

What is ASIX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ASIX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio96.7x
Fair PE Ratio154.5x

Price-To-Earnings vs Fair Ratio: ASIX is good value based on its Price-To-Earnings Ratio (96.7x) compared to the estimated Fair Price-To-Earnings Ratio (154.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ASIX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$30.68
US$35.50
+15.7%
1.4%US$36.00US$35.00n/a2
Oct ’25US$30.22
US$35.50
+17.5%
1.4%US$36.00US$35.00n/a2
Sep ’25US$29.56
US$35.50
+20.1%
1.4%US$36.00US$35.00n/a2
Aug ’25US$26.74
US$34.00
+27.2%
5.9%US$36.00US$32.00n/a2
Jul ’25US$22.07
US$34.00
+54.1%
5.9%US$36.00US$32.00n/a2
Jun ’25US$23.70
US$37.00
+56.1%
12.3%US$43.00US$32.00n/a3
May ’25US$25.51
US$38.33
+50.3%
8.6%US$43.00US$36.00n/a3
Apr ’25US$27.20
US$37.33
+37.3%
5.1%US$40.00US$36.00n/a3
Mar ’25US$27.27
US$37.33
+36.9%
5.1%US$40.00US$36.00n/a3
Feb ’25US$26.07
US$38.67
+48.3%
6.5%US$42.00US$36.00n/a3
Jan ’25US$29.96
US$40.67
+35.7%
12.9%US$48.00US$36.00n/a3
Dec ’24US$26.68
US$40.67
+52.4%
12.9%US$48.00US$36.00n/a3
Nov ’24US$27.23
US$47.00
+72.6%
15.4%US$57.00US$40.00n/a3
Oct ’24US$31.08
US$51.67
+66.2%
7.5%US$57.00US$48.00US$30.223
Sep ’24US$33.88
US$51.67
+52.5%
7.5%US$57.00US$48.00US$29.563
Aug ’24US$40.27
US$51.00
+26.6%
5.8%US$55.00US$48.00US$26.743
Jul ’24US$34.98
US$51.00
+45.8%
5.8%US$55.00US$48.00US$22.073
Jun ’24US$33.35
US$51.00
+52.9%
5.8%US$55.00US$48.00US$23.703
May ’24US$37.44
US$53.67
+43.3%
5.3%US$57.00US$50.00US$25.513
Apr ’24US$38.27
US$54.67
+42.8%
9.6%US$62.00US$50.00US$27.203
Mar ’24US$41.21
US$54.67
+32.7%
9.6%US$62.00US$50.00US$27.273
Feb ’24US$43.64
US$55.33
+26.8%
8.5%US$62.00US$52.00US$26.073
Jan ’24US$38.02
US$58.33
+53.4%
15.4%US$71.00US$52.00US$29.963
Dec ’23US$41.03
US$58.33
+42.2%
15.4%US$71.00US$52.00US$26.683
Nov ’23US$36.80
US$57.33
+55.8%
19.0%US$72.00US$46.00US$27.233
Oct ’23US$32.10
US$63.33
+97.3%
14.7%US$76.00US$54.00US$31.083

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies